Overview

Sepsis Diagnostics Market is poised to value over CAGR of over 8.8% during the forecast period 2022 to 2028.

The increasing geriatric population across the world, regulated governmental initiatives for creating awareness regarding sepsis are some of the primary reasons for the remarkable proliferation of the sepsis diagnostics market. According to a study conducted by the WHO, the number of patients diagnosed with sepsis were over 30 million in 2018, leading to over 5 million deaths every year. Such a high prevalence of sepsis is predicted to increase the requirement for diagnostic solutions, thus augmenting the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Sepsis Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Sepsis Diagnostics Market:

• Biomérieux
• T2 Biosystems
• Luminex
• Becton,Dickinson,And Company (Bd)
• Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
• Danaher
• Thermo Fisher Scientific
• Bruker
• Abbott
• Immunexpress
• Response Biomedical
• Axis-Shield Diagnostics
• Cytosorbents
• Mitsubishi Chemical Europe
• Ekf Diagnostics  

(Note: The list of the major players will be updated with the latest market scenario and trends)

Sepsis Diagnostics Market Segmentation:

By Technology

• Blood Culture
• Immunoassays
• Molecular Diagnostics
  o PCR
  o Peptide Nucleic Acid-Fluorescent In Situ Hybridization
  o Microarrays
  o Syndromic Panel-Based Testing
• Flow Cytometry
• Microfluidics
• Biomarkers

By Product

• Blood Culture Media
• Assays & Reagents
• Instruments
• Software

By Pathogen

•  Bacterial Sepsis
    o  Gram-positive bacteria
    o  Gram-negative bacteria
•  Fungal Sepsis
•  Other Pathogens

By Method

• Conventional Diagnostics
• Automated Diagnostics

By Test Type

• Laboratory Tests
• Point-of-care Tests

By End User

• Hospitals
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Sepsis Diagnostics Market By Technology, By Product, By Pathogen, By Method, By Test Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Sepsis Diagnostics Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Sepsis Diagnostics Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Sepsis Diagnostics Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Sepsis Diagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Blood Culture
   7.2. Immunoassays
   7.3. Molecular Diagnostics
        7.3.1. PCR
        7.3.2. Peptide Nucleic Acid-Fluorescent In Situ Hybridization
        7.3.3. Microarrays
        7.3.4. Syndromic Panel-Based Testing
   7.4. Flow Cytometry
   7.5. Microfluidics
   7.6. Biomarkers

8. Sepsis Diagnostics Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Blood Culture Media
   8.2. Assays & Reagents
   8.3. Instruments
   8.4. Software 

9. Sepsis Diagnostics Market, By Pathogen Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Bacterial Sepsis
        9.1.1. Gram-positive bacteria
        9.1.2. Gram-negative bacteria
   9.2. Fungal Sepsis
   9.3. Other Pathogens 

10. Sepsis Diagnostics Market, By Method Historical Analysis and Forecast 2022-2028 (USD Million)  
    10.1. Conventional Diagnostics
    10.2. Automated Diagnostics 
  
11. Sepsis Diagnostics Market, By Test Type Historical Analysis and Forecast 2022-2028 (USD Million)  
    11.1. Laboratory Tests
    11.2. Point-of-care Tests

12. Sepsis Diagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
    12.1. Hospitals
    12.2. Pathology & Reference Laboratories  
    12.3. Research Laboratories & Academic Institutes

13. North America Sepsis Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. U.S.A
          13.2.2. Canada
          13.2.3. Mexico
    13.3. Market Size (USD Million) Forecast for North America 2022-2028

14. Latin America Sepsis Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Brazil
          14.2.2. Venezuela
          14.2.3. Argentina
          14.2.4. Rest of Latin America
    14.3. Market Size (USD Million) Forecast for Latin America 2022-2028

15. Europe Sepsis Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Germany
          15.2.2. U.K         
          15.2.3. France
          15.2.4. Italy
          15.2.5. Spain
          15.2.6. Russia
          15.2.7. Poland
          15.2.8. Rest of Europe
    15.3. Market Size (USD Million) Forecast for Europe 2022-2028

16. Asia Pacific Sepsis Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. Japan
          16.2.2. China
          16.2.3. India
          16.2.4. Australia and New Zealand
          16.2.5. ASEAN
          16.2.6. Rest of Asia Pacific
    16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

17. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    17.1. Introduction
    17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          17.2.1. GCC
          17.2.2. Israel
          17.2.3. South Africa
          17.2.4. Rest of MEA
    17.3. Market Size (USD Million) Forecast for MEA 2022-2028

18. Market Share Analysis and Competitive Landscape   
    18.1. Global Landscape - Key Players, Revenue and Presence
    18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    18.3. Global Emerging Companies
    18.4. North America - Market Share Analysis and Key Regional Players
    18.5. Europe - Market Share Analysis and Key Regional Players
    18.6. Asia Pacific - Market Share Analysis and Key Regional Players
    18.7. Global Key Player - Growth Matrix

19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    19.1. Biomérieux
          19.1.1. Company Overview
          19.1.2. Product Portfolio
          19.1.3. SWOT Analysis
          19.1.4. Financial Overview
          19.1.5. Strategic Overview
    19.2. T2 Biosystems
          19.2.1. Company Overview
          19.2.2. Product Portfolio
          19.2.3. SWOT Analysis
          19.2.4. Financial Overview
          19.2.5. Strategic Overview 
    19.3. Luminex
          19.3.1. Company Overview
          19.3.2. Product Portfolio
          19.3.3. SWOT Analysis
          19.3.4. Financial Overview
          19.3.5. Strategic Overview
    19.4. Becton,Dickinson and Company (Bd)
          19.4.1. Company Overview
          19.4.2. Product Portfolio
          19.4.3. SWOT Analysis
          19.4.4. Financial Overview
          19.4.5. Strategic Overview
    19.5. Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
          19.5.1. Company Overview
          19.5.2. Product Portfolio
          19.5.3. SWOT Analysis
          19.5.4. Financial Overview
          19.5.5. Strategic Overview
    19.6. Danaher
          19.6.1. Company Overview
          19.6.2. Product Portfolio
          19.6.3. SWOT Analysis
          19.6.4. Financial Overview
          19.6.5. Strategic Overview      
    19.7. Thermo Fisher Scientific
          19.7.1. Company Overview
          19.7.2. Product Portfolio
          19.7.3. SWOT Analysis
          19.7.4. Financial Overview
          19.7.5. Strategic Overview
    19.8. Bruker
          19.8.1. Company Overview
          19.8.2. Product Portfolio
          19.8.3. SWOT Analysis
          19.8.4. Financial Overview
          19.8.5. Strategic Overview 
    19.9. Abbott
          19.9.1. Company Overview
          19.9.2. Product Portfolio
          19.9.3. SWOT Analysis
          19.9.4. Financial Overview
          19.9.5. Strategic Overview
    19.10.Immunexpress
          19.10.1. Company Overview
          19.10.2. Product Portfolio
          19.10.3. SWOT Analysis
          19.10.4. Financial Overview
          19.10.5. Strategic Overview
    19.11.Response Biomedical
          19.11.1. Company Overview
          19.11.2. Product Portfolio
          19.11.3. SWOT Analysis
          19.11.4. Financial Overview
          19.11.5. Strategic Overview      
    19.12.Axis-Shield Diagnostics
          19.12.1. Company Overview
          19.12.2. Product Portfolio
          19.12.3. SWOT Analysis
          19.12.4. Financial Overview
          19.12.5. Strategic Overview
    19.13.Cytosorbents
          19.13.1. Company Overview
          19.13.2. Product Portfolio
          19.13.3. SWOT Analysis
          19.13.4. Financial Overview
          19.13.5. Strategic Overview 
    19.14.Mitsubishi Chemical Europe
          19.14.1. Company Overview
          19.14.2. Product Portfolio
          19.14.3. SWOT Analysis
          19.14.4. Financial Overview
          19.14.5. Strategic Overview 
    19.15.Ekf Diagnostics
          19.15.1. Company Overview
          19.15.2. Product Portfolio
          19.15.3. SWOT Analysis
          19.15.4. Financial Overview
          19.15.5. Strategic Overview 

20. Pre and Post COVID-19 Impact
    20.1. Positive influence on the healthcare industry
    20.2. The financial disruption of the manufacturing sector
    20.3. Impact of COVID-19 on emerging companies
    20.4. Significant mandates in the healthcare regulations initiated by administrations
    20.5. The overall economic slowdown of the developing and developed nations

21. FutureWise SME Key Takeaway Points for Client

Tables

Figures